DEF: Performant Healthcare Sets Date for 2025 Annual Stockholders Meeting
Sentiment:
Proxy Statement
Performant Healthcare announces its 2025 Annual Meeting of Stockholders to be held on June 18, 2025, to elect directors and ratify the appointment of its independent auditor.
Summary
- Performant Healthcare, Inc. will hold its 2025 Annual Meeting of Stockholders on June 18, 2025, at 2:00 PM EDT in Weston, Florida.
- Stockholders of record as of April 23, 2025, are entitled to vote on the election of three Class I directors and the ratification of Baker Tilly US, LLP as the independent registered public accounting firm for 2025.
- The board of directors recommends voting 'FOR' the election of the director nominees and 'FOR' the ratification of the auditor appointment.
- The proxy statement and voting instructions are available online, with paper copies available upon request.
- The board of directors consists of seven members divided into three classes with staggered three-year terms.
- Non-employee independent directors receive an annual retainer of $40,000 plus additional retainers for committee service and an annual grant of restricted stock units with a fair value of $130,000.
- Executive compensation includes base salary, cash-based incentive compensation tied to revenue and EBITDA, and equity-based compensation.
- In 2024, the company's actual healthcare market revenue of $118 million met the 90% threshold, making the 65% 2024 plan revenue component partially eligible for payout, while actual EBITDA did not meet the 90% threshold, so none of the 35% 2024 plan EBITDA component was eligible for payout.
- The company has share ownership guidelines for executive officers, requiring the CEO to own shares worth at least four times their annual base salary and other executive officers to own shares worth at least two times their annual base salary.
- The company has an incentive-based compensation recoupment (clawback) policy.
- As of April 23, 2025, there were 78,308,640 shares of Common Stock outstanding.
- Prescott Group Capital Management, LLC is the largest stockholder with 20.1% ownership.
Sentiment
Score: 6
Explanation: The document is primarily informational, outlining the details of the annual meeting and corporate governance. The sentiment is neutral, with some positive aspects related to governance and compensation practices, but also some negative aspects related to missed EBITDA targets and a late filing.
Positives
- The company has established corporate governance guidelines and ethics policies.
- The board of directors is composed of a majority of independent directors.
- The company has an incentive-based compensation recoupment (clawback) policy.
- The company offers a 401(k) plan with employer matching contributions.
- The company has share ownership guidelines for executive officers to align their interests with those of stockholders.
Negatives
- Actual EBITDA did not meet the 90% threshold, so none of the 35% 2024 plan EBITDA component was eligible for payout.
- A Form 4 filing for Rohit Ramchandani was filed late.
Risks
- Cybersecurity risks are a concern due to the sensitive personal information handled by the company.
- The company's performance is tied to achieving revenue and EBITDA targets, which may be subject to market fluctuations and other external factors.
- Failure to comply with insider trading laws and regulations could result in penalties.
Future Outlook
The company aims to achieve long-term revenue targets of $135 million, $155 million, and $175 million to vest performance stock units granted to executives.
Industry Context
The document does not provide specific details on how Performant Healthcare's announcements relate to broader industry trends or competitors.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Lisa C. Im | Simeon M. Kohl | 2023-05-05 | Ms. Im resigned from her position as Chief Executive Officer of the Company and was appointed by the board of directors to serve as Executive Chair of the board of directors. |
| Chief Financial Officer | NA | Rohit Ramchandani | 2023-05-05 | Mr. Ramchandani was appointed as the Chief Financial Officer of the Company. |
| Vice President and Chief Accounting Officer | Ian A. Johnston | NA | 2024-05-07 | Mr. Johnston resigned from his position as Vice President and Chief Accounting Officer. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Adoption of Incentive-Based Compensation Recoupment (Clawback) Policy | The board of directors adopted an incentive-based compensation recoupment (clawback) policy that complies with the final regulations adopted by the SEC to implement the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the listing standards adopted by The Nasdaq Stock Market to implement those SEC regulations. | 2023-11 | The policy allows the company to recover erroneously awarded incentive-based compensation previously paid to the company's covered executives in the event the company is required to prepare an accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. |
Related Party Transactions
- We did not conduct any transactions with related parties in 2024 that would require disclosure in this proxy statement or that required approval pursuant to the policy described above.
Stakeholder Impact
- Stockholders are encouraged to participate in the Annual Meeting and vote on key proposals.
- Executive compensation is designed to align with stockholder interests and reward performance.
- The company's governance practices aim to ensure transparency and accountability to stakeholders.
Next Steps
- Stockholders are encouraged to vote their shares by proxy before the Annual Meeting.
- The company will hold its Annual Meeting on June 18, 2025.
- The board will continue to evaluate its leadership structure and compensation policies.
Key Dates
| Date | Description |
|---|---|
| 2011-12 | William D. Hansen joined the board of directors. |
| 2014-02 | Bradley M. Fluegel joined the board of directors. |
| 2014-08 | Lisa C. Im was elected as the Chair of the board of directors. |
| 2019-11 | James LaCamp joined the board of directors. |
| 2020-05-05 | Eric Yanagi was appointed to the board of directors. |
| 2021-04 | Board of directors adopted share ownership guidelines for executive officers. |
| 2023-05 | Lisa C. Im became Executive Chair of the board of directors, and Simeon M. Kohl became Chief Executive Officer. |
| 2023-05 | Rohit Ramchandani was appointed as the Chief Financial Officer. |
| 2023-11 | Board of directors adopted an incentive-based compensation recoupment (clawback) policy. |
| 2024-03 | Shantanu Agrawal joined the board of directors. |
| 2024-03-26 | Award of restricted stock units to Rohit Ramchandani. |
| 2024-04-23 | Record date for determining stockholders entitled to notice of the Annual Meeting and to vote at the Annual Meeting. |
| 2024-04-26 | Employment agreements with Simeon Kohl and Rohit Ramchandani were entered into. |
| 2024-05-07 | Ian A. Johnston resigned from his position as Vice President and Chief Accounting Officer. |
| 2024-08 | Board of directors and compensation committee approved equity awards to Mr. Kohl and Mr. Ramchandani. |
| 2025-04-23 | Record date for the 2025 Annual Meeting. |
| 2025-06-18 | Date of the 2025 Annual Meeting of Stockholders. |
| 2026 | Terms of Class II directors expire. |
| 2027 | Terms of Class III directors expire. |
| 2028 | Terms of Class I directors expire. |
Keywords
proxy statement, annual meeting, directors, executive compensation, corporate governance, audit committee, stockholders, Baker Tilly, Performant Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.